Arabian International Healthcare Holding Company (9530.SR) — Income statement
Revenue, gross profit, operating income, net income, and EPS for Arabian International Healthcare Holding Company — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 842↑3.4% | 814↑0.9% | 807↑25.6% | 643↑3.9% | 619 | |
| Cost of Revenue | 656↑6.0% | 619↑0.4% | 617↑26.3% | 489↑2.8% | 475 | |
| Gross Profit | 186↑3.3% | 180↓5.3% | 190↑23.2% | 154↑7.4% | 144 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00↓100.0% | 63↑245.8% | 18↑43.3% | 13↑32.6% | 10 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 86↑345.5% | 19↑31.4% | 15↑55.7% | 9 | |
| SG&A Expenses | 120↓20.2% | 151↑303.3% | 37↑36.9% | 27↑44.1% | 19 | |
| Other Expenses | 0.00↓100.0% | 93↓17.8% | 113↑69.8% | 66↑279.8% | 17 | |
| Operating Expenses | 120↓50.6% | 243↑62.3% | 150↑60.2% | 94↑157.1% | 36 | |
| Total Costs & Expenses | 777↓10.0% | 863↑12.5% | 767↑31.7% | 582↑13.8% | 511 | |
| Operating Results | ||||||
| Operating Income | 66↑124.9% | 29↓27.1% | 40↓33.8% | 61↓43.5% | 107 | |
| Depreciation & Amortization | 9↓50.2% | 18↑16.1% | 15↑52.8% | 10↑38.3% | 7 | |
| EBITDA | 75↑785.4% | 8↓92.4% | 111↑70.6% | 65↓38.8% | 106 | |
| EBIT | 66↑803.9% | -9↓109.7% | 96↑73.9% | 55↓44.5% | 99 | |
| Interest & Other Income | ||||||
| Net Interest Income | -38↑6.8% | -41↓18.3% | -35↓64.0% | -21↓24.9% | -17 | |
| Interest Income | 2↓62.5% | 5↓4.5% | 5↑613.3% | 0.72↓94.5% | 13 | |
| Interest Expense | 40↓12.7% | 46↑15.4% | 40↑81.9% | 22↑68.6% | 13 | |
| Non-Operating Income | 0.00↓100.0% | 39↑295.0% | -20↓383.1% | 7↓73.2% | 26 | |
| Other Income / Expenses | -27↑70.2% | -90↓751.6% | 14↑157.8% | -24↓79.3% | -13 | |
| Income Before Tax | 39↑163.5% | -61↓213.3% | 54↑47.4% | 37↓61.0% | 94 | |
| Income Tax Expense | 10↑5.4% | 10↓16.7% | 12↑6.2% | 11↓4.6% | 11 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 29↑140.4% | -71↓267.0% | 42↑64.7% | 26↓68.8% | 82 | |
| Net Income from Discontinued Operations | -9 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 24↑135.7% | -67↓274.9% | 38↑86.0% | 20↓75.1% | 82 | |
| Bottom-Line Net Income | 24↑135.7% | -67↓274.9% | 38↑86.0% | 20↓75.1% | 82 | |
| EPS (Basic) | 1.20↑135.6% | -3.37↓275.5% | 1.92↑88.2% | 1.02↓75.2% | 4.12 | |
| EPS (Diluted) | 1.20↑135.6% | -3.37↓275.5% | 1.92↑88.2% | 1.02↓75.2% | 4.12 | |
| Weighted Average Shares | 20↑0.0% | 20↑0.0% | 20↓0.9% | 20↓0.1% | 20 | |
| Weighted Average Diluted Shares | 20↑0.0% | 20↑0.0% | 20↓0.9% | 20↓0.1% | 20 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.